Turkish Adaptation, Validity and Reliability of Community Integration Questionnaire-Revised (CIQ-R)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The reliability and validity of the scale will begin with language equivalence and cultural adaptation. The scale will be translated from English to Turkish by two people who are fluent in Turkish and English. A single Turkish translation will be obtained from these two Turkish translations with a common opinion.
The scale, which has been translated into Turkish, will be translated into English by two other people who are fluent in Turkish and English. The scale translated into English will be compared with the original. If the developer of the scale, Callaway and Willer approves the translation of the scale, participants will be recruited for the study. In the pre-trial phase, a reassessment will be conducted with 15 participants to test the intelligibility of the scale. Based on the results of the pre-test phase, the final version of CIQ-R will be able to be modified. The data of CIQ-R are collecting through face-to-face when the patients came to the rehabilitation center. 145 participants will be included in the study.
In order to evaluate the validity of the CIQ-R, the Mini Mental State Examination (MMSE), which can evaluates general cognitive functioning and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34854
- Emel Mete
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients with
- duration of hemiplegia ≤ 3 year
- able to speak and read Turkish
- those with a Mini Mental State Examination score of 24 and above
Exclusion Criteria: Patients with
- communication or cognitive problems,
- aphasia and speech disorders
- unstable medical conditions
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
stroke patients
The aim of this study is to adapt the Community Integration Questionnaire-Revised (CIQ-R)scale to Turkish society in stroke patients and to make its validity and reliability in Turkish.
|
The aim of this study is to adapt the Community Integration Questionnaire-Revised (CIQ-R)scale to Turkish society and to make its validity and reliability in Turkish.
It has 18 questions.
This study will be conducted with stroke patients.
The patients will be sought to answer questionnaires during regular rehabilitation sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
community integration
Time Frame: baseline
|
community integration will be assessed with the Community Integration Questionnaire-Revised (CIQ-R) scale. It consists of 18 items in total. Each item is scored on a scale of 0-2 includes four sub-categories: Home Integration (HI), Social Integration (SI), Productivity (P), and Electronic Social Network (ESN). The total score is the calculated sum of 18 items. The minimum score is 0 and the maximum score is 35 points. Higher scores indicate a high level of community integration which means better community integration. |
baseline
|
|
Cognitive function
Time Frame: baseline
|
The Mini-Mental State Examination (MMSE), which is a widely used cognitive assessment questionnaire is quite short.
It evaluates general cognitive functioning (especially in the left cerebral hemisphere) and ranged from 0 to 30 points.
According to the scale results; It is accepted that there is severe cognitive influence between 0-17 points, moderate cognitive influence between 18-23 points, and no cognitive influence between 24-30 points.
Higher scores mean better cognitive function.
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIQ-R
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.